Long-term outcome in kidney recipients from donors treated with hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6

Br J Anaesth. 2015 Nov;115(5):798. doi: 10.1093/bja/aev335.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Brain Death
  • Creatinine / blood
  • Follow-Up Studies
  • Graft Rejection
  • Humans
  • Hydroxyethyl Starch Derivatives / analogs & derivatives*
  • Hydroxyethyl Starch Derivatives / therapeutic use
  • Kidney Transplantation*
  • Retrospective Studies
  • Tissue Donors
  • Treatment Outcome

Substances

  • HES 130-0.4
  • Hydroxyethyl Starch Derivatives
  • hydroxyethylstarch 200
  • Creatinine